GSK Invests $30 Billion in US Amid Global Shift in Pharmaceutical Hubs
In a significant shift, the head of UK-based pharmaceutical giant GSK, Dame Emma Walmsley, has declared the United States as the most favorable destination for investment, citing its lucrative market and favorable business environment. The company pl